According to Bloomberg, Australia’s Challenger has rejected a revised A$6.5 billion takeover offer—valued at approximately $4.4 billion—from Japan’s Daiichi Life Group. This marks the second time Daiichi Life has been rebuffed within a month, with the proposal having been turned down rather than a deal being completed.